SMLR vs. AXGN, ZYXI, OM, EDAP, ELMD, FONR, VANI, HYPR, ECOR, and CUTR
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include AxoGen (AXGN), Zynex (ZYXI), Outset Medical (OM), Edap Tms (EDAP), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), electroCore (ECOR), and Cutera (CUTR). These companies are all part of the "electromedical equipment" industry.
AxoGen (NASDAQ:AXGN) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.
AxoGen presently has a consensus price target of $10.67, indicating a potential upside of 53.04%. Given Semler Scientific's higher possible upside, research analysts clearly believe AxoGen is more favorable than Semler Scientific.
AxoGen received 444 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 72.48% of users gave AxoGen an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote.
Semler Scientific has lower revenue, but higher earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
In the previous week, Semler Scientific had 1 more articles in the media than AxoGen. MarketBeat recorded 1 mentions for Semler Scientific and 0 mentions for AxoGen. AxoGen's average media sentiment score of 0.97 beat Semler Scientific's score of 0.00 indicating that Semler Scientific is being referred to more favorably in the news media.
80.3% of AxoGen shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 7.0% of AxoGen shares are owned by insiders. Comparatively, 13.0% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Semler Scientific has a net margin of 32.92% compared to Semler Scientific's net margin of -12.99%. AxoGen's return on equity of 30.36% beat Semler Scientific's return on equity.
AxoGen has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500.
Summary
Semler Scientific beats AxoGen on 12 of the 19 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
